Directory
>
Julie Lepin
Julie Lepin
Member of the Board of Advisors | Athena Alliance
Oak Park, California, United States
Julie Lepin
Summary
Julie Lepin is a seasoned regulatory affairs professional with over 20 years of global experience in the biopharmaceutical sector. As the Senior Vice President at Sana Biotechnology, she excels in defining regulatory strategies for drug development and marketing authorization. Her extensive expertise spans oncology, pharmacovigilance, and regulatory submissions across major markets including the USA, Europe, and Japan. Julie has a proven track record of building high-performing teams and nurturing talent within the regulatory landscape. She is actively involved in professional organizations such as Chief and Athena Alliance, advocating for women in leadership roles. Fluent in both English and French, she brings a multicultural perspective to her work. Julie's commitment to innovation in life sciences is evident in her strategic approach to regulatory challenges. She is not only a leader but also a mentor, dedicated to empowering the next generation of professionals in her field.
Julie Lepin
Work Experience
Member of the Board of Advisors at
Product Life
April 2023 - Present
Member of Athena Alliance at
Athena Alliance
February 2023 - Present
Member of Chief at
Project 1972, Inc.
May 2022 - Present
Member at
Project 1972, Inc.
April 2022 - Present
Senior Vice President, Head of Regulatory Affairs, Safety and Quality at
Sana Biotechnology, Inc.
March 2022 - Present
Vice President, Regulatory Affairs, Oncology at
Amgen, Inc.
June 2018 - March 2022
Senior Vice President at
Juno Therapeutics, Inc.
January 2018 - June 2018
Vice President Regulatory Affairs, Oncology at
Merck & Co., Inc.
October 2015 - January 2018
Executive Director, Regulatory Affairs, Intercontinental at
Amgen, Inc.
January 2012 - October 2015
Global Regulatory Affairs at
Galderma
January 2010 - February 2012
Director, U.S. And Global Regulatory Affairs at
Amgen, Inc.
July 2002 - January 2010
Manager, European Regulatory Affairs at
AMGEN EUROPE GMBH
May 1997 - July 2002
Julie Lepin
Education
Frequently Asked Questions about Julie Lepin
What is Julie Lepin email address?
Julie Lepin's primary email address is ******@amgen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Julie Lepin work for?
Julie Lepin is a Member of the Board of Advisors at Athena Alliance, a company specializing in Business, Professional, Labor, Political, & Similar Organizations .
Where Julie Lepin graduated from?
Julie Lepin holds a degree in from King's College London.
How can I directly contact Julie Lepin?
To contact Julie Lepin directly, you can use the email address ******@amgen.com. Complete contact information is available upon registration with Muraena.
Who is Julie Lepin?
Julie Lepin is a seasoned regulatory affairs professional with over 20 years of global experience in the biopharmaceutical sector. As the Senior Vice President at Sana Biotechnology, she excels in defining regulatory strategies for drug development and marketing authorization. Her extensive expertise spans oncology, pharmacovigilance, and regulatory submissions across major markets including the USA, Europe, and Japan. Julie has a proven track record of building high-performing teams and nurturing talent within the regulatory landscape. She is actively involved in professional organizations such as Chief and Athena Alliance, advocating for women in leadership roles. Fluent in both English and French, she brings a multicultural perspective to her work. Julie's commitment to innovation in life sciences is evident in her strategic approach to regulatory challenges. She is not only a leader but also a mentor, dedicated to empowering the next generation of professionals in her field.
Julie`s contact details
******@amgen.com
***********@sana.com
Colleagues
Member: Athena Alliance
Member
Member
Chief People Officer
Chief Human Resources Officer
Chief People Officer
Executive Ally
Member Success Manager
Member